JNJ-67484703

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-67484703, covering 2025-05-23 to 2025-05-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of JNJ-67484703 in Participants With Active Rheumatoid Arthritis [Phase 1]